U.S. markets closed

Koios Beverage Corp. (KBEVF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1110-0.0064 (-5.43%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1174
Open0.1150
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0981 - 0.1219
52 Week Range0.0300 - 0.1500
Volume1,363,082
Avg. Volume621,400
Market Cap8.709M
Beta (5Y Monthly)2.24
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Sprouts Farmers Market Picks up All Nine SKUs of KOIOS™ and Fit Soda™
      GlobeNewswire

      Sprouts Farmers Market Picks up All Nine SKUs of KOIOS™ and Fit Soda™

      DENVER and VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the "Company" or "Koios") is pleased to announce that its KOIOS™ nootropic beverages and Fit Soda™ functional beverages (collectively, “Koios Beverages”) have been approved for placement at Sprouts Farmers Market (“Sprouts”) (NASDAQ: SFM) who has more than 360 stores in 23 states. With the addition of Sprouts, the brand will now be carried in more than 4,200 stores across various regions of the United States. Sprouts inspires wellness naturally with a carefully curated assortment of better-for-you products and a strong focus on customer service among its more than 35,000 team members. Team members are trained to educate customers about the thousands of products offered, which also include cutting-edge vitamins and supplements made using strict quality standards and ethically sourced ingredients. In addition to personalized service, Sprouts offers resources on sprouts.com to educate customers on health topics such as nootropics and cognitive health. The following SKUs of Koios Beverages will be available in Sprouts beginning in April 2021: KOIOS™ Nootropic Beverage: KOIOS™ is designed to naturally support focus, memory, mental drive, clarity, and energy. Apricot VanillaBlack RaspberryBlood OrangePeach MangoPear Guava Fit Soda™ Functional Beverage: Fit Soda™ is designed to deliver nutrients to the body, but still taste like soda. It is infused with BCAAs and electrolytes. Black Cherry ColaOrange CreamRoot Beer Vanilla FloatSparkling Citrus Koios Chief Executive Officer Chris Miller commented, “As a company centered in health and wellness, we’re thrilled to partner with Sprouts as our first national retail partner to carry all nine SKUs simultaneously. Our products are designed to support cognitive function and nutrition, which meets the needs of Sprouts’ shoppers who are looking for innovative and differentiated products made with quality ingredients.” On behalf of the Board of Directors of the Company, KOIOS BEVERAGE CORP. “Chris Miller” Chris Miller, CEO, and Director For further information, please contact: Gina Burrus844-255-6467gina@koiosbeveragecorp.com THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE. About Koios Beverage Corp. The Company is an emerging functional beverage company which has an available distribution network of more than 4,400 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain. Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.koiosbeveragecorp.com. Forward-Looking Statements This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information in this news release includes statements regarding: Potential placements following Sprouts’ approval of Koios Beverages to be placed in their supermarkets in the United States. The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual's health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease. This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by Koios with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with Koios is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.

    • Koios Expands Texas Presence with Upcoming Placements in Select Stores of Drug Emporium, a Pharmacy Chain in TX, AR, LA
      GlobeNewswire

      Koios Expands Texas Presence with Upcoming Placements in Select Stores of Drug Emporium, a Pharmacy Chain in TX, AR, LA

      Koios Drug Emporium’s 2019 reopening was featured in a televised news broadcast on KAMC, local ABC affiliate for Lubbock, Texas. In this segment, the General Manager of Drug Emporium’s Lubbock location explains the chain’s approach to doing business and the role of carrying hard-to-find or new-to-market products as a potential competitive advantage. Drug Emporium is a chain of “big box” pharmacies in Texas, Arkansas, and Louisiana with standard pharmacy departments as well as “store-within-a-store” features such as “Vitamins Plus”. This month, the Company’s KOIOS™ and Fit Soda™ beverage products will be placed in select Texas locations of Drug Emporium, complementing existing placements of the Company’s products in the state of Texas, including in more than 100 HEB supermarkets. DENVER and VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the "Company" or "Koios") is pleased to announce that beginning this month, all five flavours of its KOIOS™ nootropic beverage and all four flavours of its Fit Soda™ functional beverage will be carried in select Texas locations of Drug Emporium, a “big box” pharmacy chain with stores in Texas (population 29 million), Arkansas (population 3 million), and Louisiana (population 4.65 million). In late 2020, the Company announced that its Fit Soda™ functional beverage product is now carried in more than 100 HEB supermarkets in Texas. Additionally, the Company announced last week that its KOIOS™ nootropic beverage product was to be added to all locations of Louisiana supermarket chain Matherne’s including its storefront located across from the Louisiana State University’s Tiger Stadium, which is the eighth-largest stadium in the world. The Company has sustained its focus on placing its beverage products with regional grocery chains who can play a key role in accelerating market penetration in a given geographic region. By adding to its existing presence in the southeastern United States through local chains such as Drug Emporium and national banner retailers such as Walmart, the Company believes that it is favourably positioned to gain greater market share in the functional beverages category. The Company’s beverage products are currently sold in more than 4,000 stores in the United States. Drug Emporium was originally founded in 1977 in Columbus, Ohio, and in the late 1990s had more than 140 company-owned stores under the banners Drug Emporium, F&M Super Drug Stores, and Vix Drug Stores, in addition to 50 franchised stores. In 1997, Drug Emporium was set to become the first drug store on the Internet, with integration into its retail operations and licenses to fill prescriptions in all 50 states1. After falling into bankruptcy in 20012, Drug Emporium was reopened in 2019 and sought to gain a competitive advantage by carrying a unique product selection heavily influenced by requests from customers3. In addition to standard pharmacy departments (e.g., medical, cosmetics, health foods), Drug Emporium locations feature “store-within-a-store” sections including Vitamins Plus, where KOIOS™ and Fit Soda™ beverages are to be merchandised. Hearing our customers say things like "I haven't seen these in years!" or "I didn't even know they made these!" is a joy to us, because it means we are meeting needs our customers didn't even know they had. Excerpt from Drug Emporium’s “About” Page A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/38851f79-ada4-4e10-8c2c-7f8659aa8fde Readers using news aggregation services may be unable to view the media above. Please access the Company’s profile on SEDAR for a version of this press release containing all published media. Select Texas locations of Drug Emporium will begin carrying KOIOS™ nootropic beverages and Fit Soda™ functional beverages this month, which contain a combination of ingredients to include lion’s mane mushroom, electrolytes, and coconut MCT oil. This combination has been shown to boost mental drive and improve immune health. Koios Chief Executive Officer Chris Miller commented, “Drug Emporium is very transparent about just how seriously they take requests from their customers when it comes to their merchandising decisions, and we believe that requests from our existing customers in their local markets could have contributed to their decision to carry our beverage product lines. Between several independent and chain retailers in these regions as well as a pipeline of direct-to-consumer orders from individuals in Texas, we believe that Drug Emporium’s decision to carry KOIOS™ and Fit Soda™ could be conducive to even further growth in the southern states, as we continue our initiatives with an objective of building a brand footprint that spans the entire country. We look forward to seeing how KOIOS™ performs in Drug Emporium stores as we seek to make 2021 our most prosperous year yet.” Sources 1 - https://sec.report/Document/0000950152-99-004734/ 2 - https://apnews.com/article/5be452de9c2256ca43a77f8b07b0baf6 3 - https://www.everythinglubbock.com/news/trends-and-friends/drug-emporium-hosting-grand-re-opening/ On behalf of the Board of Directors of the Company, KOIOS BEVERAGE CORP. “Chris Miller” Chris Miller, CEO, and Director For further information, please contact: Gina Burrus844-255-6467gina@koiosbeveragecorp.com THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE. About Koios Beverage Corp. The Company is an emerging functional beverage company which has an available distribution network of more than 4,400 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain. Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.koiosbeveragecorp.com. Forward-Looking Statements This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information in this news release includes statements regarding: Potential outcomes from KOIOS™ and Fit Soda™ being carried by select Drug Emporium locations in Texas beginning in March 2021. The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual's health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease. This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by Koios with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with Koios is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.

    • KOIOS™ and Fit Soda™ Now Carried by NewAge DSD, Major Beverages Distributor
      GlobeNewswire

      KOIOS™ and Fit Soda™ Now Carried by NewAge DSD, Major Beverages Distributor

      Fit Soda Fit Soda on store shelves throughout Colorado. Koios has engaged NewAge, a Denver-based distributor of beverages and snacks, to carry its KOIOS™ nootropic beverages and Fit Soda™ functional beverages throughout Colorado and potentially in other markets. Koios anticipates that NewAge’s in-depth knowledge of functional beverages, in addition to its significant footprint in Colorado can complement Koios’ existing presence in the state and potentially create new opportunities for the Company. DENVER and VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) -- Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the "Company" or "Koios") is pleased to announce that it has entered into a distribution agreement with NewAge, Inc. (“NewAge”) (NASDAQ: NBEV), a major omnichannel wholesaler of beverages and snacks. Based in Denver Colorado, NewAge provides direct store delivery (“DSD”) service for beverage brands all across the state of Colorado, primarily in the Front Range region. Koios believes its engagement with NewAge can strengthen the Company’s existing presence in Colorado, which benefits from Koios’ prestige as a local business. NewAge will distribute all of Koios’ beverage products including KOIOS™ nootropic beverages and Fit Soda™ functional beverages (collectively, the “Koios Beverages”). In 2021 the Company announced several placements of Koios Beverages in local grocery chains in regions to include New England, Utah, Oregon, Louisiana, Massachusetts, and California, in addition to a placement of Fit Soda™ in over 100 HEB supermarkets in Texas announced in November 2020. With approval for Koios Beverages to be sold through the NewAge distribution network, new placements could be finalized much more rapidly and enable the Company to further grow its base of more than 4,000 points of sale in the United States. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/26a7cda1-dd9b-442a-938d-4ccc8f5a57ae Koios is a beverage producer based out of Denver, Colorado with a product portfolio that includes functional beverages, supplements, and specialty coffees. Its KOIOS™ nootropic beverage product is offered in five flavours and contains ingredients that have been shown to improve mental clarity, cognitive abilities, and immunity. Offered in four flavours, the Company’s Fit Soda™ functional beverage has also had strong reception from consumers in the United States, with availability through Walmart’s U.S. online store and presence in brick-and-mortar grocery stores, foodservice outlets, and sports nutrition retailers in Colorado, California, Wisconsin, and Texas. With representation of Koios Beverages through a distributor such as NewAge, the Company anticipates it can expand availability of its products in existing markets. NewAge was founded in 2003, and grew from representing a single brand of bottled water to representing a diversified portfolio of brands across categories that include non-alcoholic beverages, salty snacks, beer, and spirits. Each of NewAge’s product categories has dedicated routes and teams to ensure efficient performance. Despite the general economic effects of the COVID-19 pandemic, NewAge’s DSD division enjoyed record performance in 2020 and has sustained this success in 2021. In a recent statement by Josh Hillegass, President of NewAge’s DSD division, Mr. Hillegass stated that the division’s impressive team has played a key role in this strong performance by navigating the present challenging circumstances. More information about NewAge can be found on its website: http://newage.com. Koios Chief Executive Officer Chris Miller commented, “We are thrilled to be working with NewAge, as they have been a leader in functional beverage distribution in the state of Colorado for many years. With their innovative DSD model, NewAge provides a number of advantages to brands including offering a ‘test bed’ for new products before doing national rollouts, forecasting of emerging products and segments, and providing top-notch service aligning with all stakeholders in the beverage supply chain. To us, NewAge is more than a distributor; they are an extension of the Koios family. Partnering with NewAge allows us to expand our sales team and reach more stores than we ever could independently. In addition to their impressive reach in Colorado, their network across the United States and internationally can allow us to leverage their expertise and connections to help us scale our market position. Our partnership with NewAge DSD could also enable us to enhance our current position in the convenience store channel, with more than 200 stores in Colorado alone. We believe Fit Soda™ will be a fast mover in this vertical, which could present tremendous opportunity for growth. Josh and his team at NewAge have helped build some of the largest beverage brands in the United States, so we are incredibly excited to be working with them and utilizing their expertise.” On behalf of the Board of Directors of the Company, KOIOS BEVERAGE CORP. “Chris Miller” Chris Miller, CEO, and Director For further information, please contact: Gina Burrus844-255-6467gina@koiosbeveragecorp.com THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE. About Koios Beverage Corp. The Company is an emerging functional beverage company which has an available distribution network of more than 4,400 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain. Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.koiosbeveragecorp.com. Forward-Looking Statements This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information in this news release includes statements regarding: Potential outcomes of Koios Beverages being distributed by NewAge throughout its network in Colorado and potentially other markets and the conditions of the functional beverage market . The forward-looking information reflects management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual's health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease. This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by Koios with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with Koios is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.